Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Last year's invitation to shareholder meeting

Does anyone know if any proposals on the agenda are likely to be originated by a shareholder?

Is there a process or is it too late to add (or "request to be added") such an agenda item?

Also - wouldn't a By-Law change be a material event and that the before/after wording would need to be reported to SEC as such?

Share
New Message
Please login to post a reply